In the last trading session, U.S. stocks gained on stimulus hopes. Among the top ETFs, investors saw SPY gain 6%, DIA advance 5.4%, and QQQ move 7.6% higher on the day on stimulus hopes.
Two more specialized ETFs are worth noting as both saw trading volume that was far outside of normal. In fact, both these funds experienced volume levels that were more than double their average for the most recent trading session. This could make these ETFs ones to watch out for in the days ahead to see if this trend of extra-interest continues.
XLK: Volume 3.22 Times Average
This technology ETF was in the spotlight as around 50.41 million shares moved hands compared with an average 16.31 million shares a day. We also saw some price movement as XLK gained 6.8% in the last session. The movement can largely be credited to the anticipated U.S. government stimulus. XLK has shed 24% in a month’s time.
XBI: Volume 3.02 Times Average
This biotech ETF was under the microscope as 18.45 million shares moved hands. This compares with average trading volume of roughly 6.33 million shares and came as XBI added 3.6% in the trading session. XBI has lost about 29% over the past month.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
In the last trading session, U.S. stocks gained on stimulus hopes. Among the top ETFs, investors saw SPY gain 6%, DIA advance 5.4%, and QQQ move 7.6% higher on the day on stimulus hopes.
Two more specialized ETFs are worth noting as both saw trading volume that was far outside of normal. In fact, both these funds experienced volume levels that were more than double their average for the most recent trading session. This could make these ETFs ones to watch out for in the days ahead to see if this trend of extra-interest continues.
XLK: Volume 3.22 Times Average
This technology ETF was in the spotlight as around 50.41 million shares moved hands compared with an average 16.31 million shares a day. We also saw some price movement as XLK gained 6.8% in the last session. The movement can largely be credited to the anticipated U.S. government stimulus. XLK has shed 24% in a month’s time.
XBI: Volume 3.02 Times Average
This biotech ETF was under the microscope as 18.45 million shares moved hands. This compares with average trading volume of roughly 6.33 million shares and came as XBI added 3.6% in the trading session. XBI has lost about 29% over the past month.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on QQQ - FREE
Get the latest research report on SPY - FREE
Get the latest research report on XLK - FREE
Get the latest research report on DIA - FREE
Get the latest research report on XBI - FREE